Showing 1 - 2 results of 2 for search 'D. C. De Leeuw', query time: 0.02s Refine Results
  1. 1
    P462: IDENTIFICATION OF TARGETED THERAPIES DIRECTED TO ACUTE MYELOID LEUKEMIA MINIMAL RESIDUAL DISEASE

    P462: IDENTIFICATION OF TARGETED THERAPIES DIRECTED TO ACUTE MYELOID LEUKEMIA MINIMAL RESIDUAL DISEASE by N. van Gils, F. Kessler, M. Broux, F. Denkers, S. Demeyer, J. Cools, D. C. De Leeuw, J. Janssen, L. Smit

    Published 2022-06-01
    Get full text
    Article
  2. 2
    P1456: EARLY SAFETY AND CLINICAL COURSE OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MEASURABLE RESIDUAL DISEASE RECEIVING GTA002, AN OFF-THE-SHELF, EX VIVO-CULTURED ALLOGENEIC NK CELL PREPARATION

    P1456: EARLY SAFETY AND CLINICAL COURSE OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MEASURABLE RESIDUAL DISEASE RECEIVING GTA002, AN OFF-THE-SHELF, EX VIVO-CULTURED ALLOGENEIC NK C... by M. Heuser, W. Fiedler, A. Block, D. C. de Leeuw, A. van de Loosdrecht, A. Astrid Tschan-Plessl, J. Passweg, A. Kloos, A. Schwarzer, L. Venturini, A. D. Duru, K. Pinkernell, A. Ganser

    Published 2022-06-01
    Get full text
    Article

Search Tools: